All posts by imreal

RAM Technologies, Inc. to Highlight CalAIM Administrative Solutions at California Association of Health Plans’ Annual Conference


RAM’s offerings and deployment options provide a simplified path that plans need to consider in support of CalAIM and beyond.

RAM Technologies, Inc. (RAM), the perennial leader in enterprise software solutions and services for Medicare Advantage and Managed Medicaid health plans, is proud to sponsor the annual conference presented by the California Association of Health Plans (CAHP). RAM will be presenting their solutions for healthcare administration with a focus on support for California Advancing and Innovating Medi-Cal (CalAIM). This year’s event will be held October 17th – 19th in Palm Desert, California.

“We are pleased to support the California Association of Health Plans and the integral work they do throughout the state,” stated Christopher P. Minton, Executive Vice President of RAM Technologies. “CAHP works diligently ensuring the availability of quality healthcare for every Californian. We appreciate their efforts and share in their vision.”

Mr. Minton added, “At this year’s conference, RAM will be presenting our market leading solutions in support of California Advancing and Innovating Medi-Cal (CalAIM). Whether an organization is new to the Medicare Advantage market and considering an outsourced solution, or contemplating a system replacement to upgrade their application portfolio, RAM’s offerings and deployment options provide a simplified path that plans need to consider in support of CalAIM and beyond.”

This year, the state of California rolled out significant portions of CalAIM, a program redesign of the state’s Medicaid program. This initiative is being delivered in partnership with managed care plans across the state and is a long-term commitment to transforming the Medi-Cal system; strengthening the program, providing a more balanced and equitable approach to delivering healthcare services, and improving the quality of life for program participants.

RAM Technologies, Inc. provides both the technology platform (SaaS) and Business Process as a Service (BPaaS) options for health plans serving the Medicare Advantage and Managed Medicaid markets. RAM’s core administrative solution, HEALTHsuite Advantage™, represents the next evolution in Medicare Advantage and Managed Medicaid administration. HEALTHsuite Advantage deploys rapidly in a pre-configured state. This innovative approach slashes implementation durations, eliminates risk and reduces total cost of ownership. HEALTHsuite Advantage’s robust features and functions include all of the essential core system capabilities, including benefit administration, enrollment, billing, reconciliation, provider data management, provider contracting and reimbursement, utilization management, encounter and claims administration, fulfillment, customer service and more including fully integrated workflow and bi-directional integration with CMS – a must for Medicare Advantage and Managed Medicaid organizations.

RAM Health Services, RAM’s internal BPaaS offering, provides health plans with the option to outsource all or select portions of their operations. This increased level of engagement affords plans, both small and large, with a wealth of expertise in government sponsored healthcare. For new market entrants, this offering is particularly attractive as it dramatically reduces time to market, alleviates hiring and HR issues and enhances health plan revenue.

About California Association of Health Plans (CAHP)

The California Association of Health Plans is a statewide trade association. CAHP works to sustain a strong environment in which their member plans can provide access to products that offer choice and flexibility to the Californians they serve. Most of their member plans provide coverage to Californians through the individual and group markets. Many member plans partner with the state by participating in government programs that provide health care coverage to children and adults in need. For more information, please visit http://www.calhealthplans.org or call (916) 552-2910.

About RAM Technologies:

RAM Technologies is the leading provider of enterprise claims processing software and CMS Integration tools for health care organizations administering Medicare Advantage, Special Needs and Managed Medicaid plans. For over 40 years RAM Technologies has led the way in the creation of benefit administration software for these programs and continues to enhance their managed care software to meet the needs of a rapidly changing market. RAM Technologies has been recognized on Inc. Magazine’s List of Fastest Growing Private Companies and the Philadelphia Business Journal’s List of Top Software Developers for their advancements in the creation of comprehensive auto adjudication software for Medicare and SNP administration. To learn more about RAM Technologies’ healthcare claims processing solutions call (877) 654-8810 or visit http://www.ramtechinc.com.

Share article on social media or email:

CS Analytical Achieves ISTA Certification for Package Testing


ISTA CERT

As an ISTA Certified Laboratory, clients can feel confident that the work we perform will help to reduce the risk of package shipment damage from the distribution cycle

CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is pleased to announce that it has it has been certified by ISTA (International Safe Transit Association) as a qualified Transport Testing Laboratory. As outlined in the ISTA program, “ISTA Transport Testing Laboratory Certification demonstrates a strong commitment to transport packaging professionalism, as well as assuring a laboratory is properly equipped to conduct ISTA® package performance testing. This certification establishes the minimum criteria to be met for transit packaging laboratories in the areas of laboratory processes and procedures, as well as equipment qualification.”

“Achievement of ISTA certification is a testament to the commitment that the CS Analytical Team has made to ensure we are positioned to help clients meet the strict regulatory demands that manufacturers have come to expect. As an ISTA Certified Laboratory, clients can feel confident that the work we perform will help to reduce the risk of package shipment damage from the distribution cycle,” noted Brian Mulhall, CEO of CS Analytical.

Package distribution testing plays a critical role in the validation of package systems for drug products and medical devices. CS Analytical is fully equipped to assist clients with all aspects of ISTA and ASTM D4169 distribution testing within an FDA regulated, strict cGMP laboratory environment. The experienced CS Analytical Team can help define a comprehensive test program that not only include ISTA and ASTM test procedures but can also include other critical aspects based upon a holistic approach. For example, the ability to marry ISTA Distribution testing to USP 1207 Leak Testing has become a common expectation. As demonstrated in the ISTA certification process, CS Analytical meets a higher standard when it comes to package distribution testing.

About CS Analytical Laboratory

The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and the thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic and elastomers as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Share article on social media or email:

Genomenon Appoints Vice President of Operations to Leadership Team


News Image

“Joining the team that is transforming how genomic information is made actionable for patients and drug development is very exciting—I look forward to helping accelerate the future of precision medicine that Genomenon is playing a role in.” –Dr. Sam Globus, VP of Operations, Genomenon

Genomenon, Inc., an AI-driven genomics company, announced today that Dr. Sam Globus has been appointed vice president of operations. To support Genomenon’s goal to curate the entire human genome, Globus will manage the rapid growth of the company’s data science and variant curation work.

Before joining Genomenon, Globus was the VP of strategy and operations at Eagle Genomics working to launch their lead product, a microbiome data analysis platform. Prior to Eagle Genomics, he was the VP of business strategy and operations at Celmatix Inc., where he helped develop and launch the world’s first genetic test for markers of infertility. While at Celmatix, he was one of the first users of Genomenon’s Mastermind® Genomic Search Engine to help his team streamline their genomic variant curation work.

“We are extremely excited to welcome Sam to the Genomenon executive leadership team,” said Mike Klein, chief executive officer, Genomenon. “As one of our first Mastermind customers, Sam understands the unique value we create for genomic researchers and clinicians. His extensive background in operations strategy will be invaluable to scaling our genomic curation work.”

Globus completed a Ph.D. in molecular biology and biochemistry from Weill Cornell University Medical College in New York City. His doctoral research at Memorial Sloan-Kettering Cancer Center focused on the basic molecular processes used to create genetic diversity in eukaryotes. In addition to his doctorate, Sam also holds an M.Sc. from University of Oxford in History of Science & Technology, an M.A. from Columbia University in Biotechnology, and a B.A. from Wesleyan University.

“I am thrilled to be joining the leadership team at Genomenon,” said Globus. “I’ve worked with Genomenon since their early days of creating the world’s first genomic search engine. Joining the team that is transforming how genomic information is made actionable for patients and drug development is very exciting—I look forward to helping accelerate the future of precision medicine that Genomenon is playing a role in.”

About Genomenon

Genomenon is an AI-driven genomics company focused on the advancement of positive health outcomes for patients with rare genetic diseases and cancer. Keeping pace with the ever-evolving body of knowledge within genomics, Genomenon connects current research with patient DNA to accelerate clinical decision-making and pharmaceutical drug discovery.

For more information, visit Genomenon.com

Share article on social media or email:

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval Webinar on September 21, 2022


The FDA’s Focus on Clinical Data Integrity

Throughout Product Development and Approval

A WCG FDAnews Webinar

Wednesday, Sep. 21, 2022, 1:30 p.m.–3:00 p.m. EDT

https://wcg.swoogo.com/fdas-focus-on-clinical-data-integrity

Clinical data must withstand FDA and Department of Justice (DOJ) scrutiny from preclinical development through clinical trials and ultimately to market approval.

This webinar will show pharmaceutical and medical device manufacturers how to ensure their data integrity is accurate and reliable throughout the whole process.

Three members of King & Spalding’s FDA and Life Sciences practice, two of whom are FDA veterans, will share what manufacturers must know and do to avoid data integrity-related FDA and DOJ enforcement action.

Beverly Lorell, senior medical and policy advisor, and partners Peter Leininger and Mark Brown will leverage hypothetical situations to highlight best practices for sponsors to identify and mitigate high-risk issues related to the integrity of clinical data. This includes its uses before and after product approval, as well as in crisis management. Attendees will learn:


  • How disruptions brought on by the COVID-19 pandemic opened the door for unintended and deliberate breaches of the development of clinical data
  • Recent trends in FDA warning letters that signal a shift from the agency’s focus during the pandemic to the emerging “new normal” of scrutiny and inspections related to the development of clinical data and its integrity
  • New modes of FDA enforcement, including those related to sponsor disclosure of clinical results on ClinicalTrials.gov
  • Key fact patterns that may trigger a DOJ decision in collaboration with the FDA to initiate criminal prosecution of an individual or firm related to fraud or falsification of clinical data used to support an application, as well as debarment by the FDA

Webinar Details

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

A WCG FDAnews Webinar

Wednesday, Sep. 21, 2022, 1:30 p.m.–3:00 p.m. EDT

https://wcg.swoogo.com/fdas-focus-on-clinical-data-integrity

Price:

$287

Easy Ways to Order:

Online: https://wcg.swoogo.com/fdas-focus-on-clinical-data-integrity

By phone: 888.838.5578 or 703.538.7600

About WCG FDAnews:

WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews’ newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations. Learn more at fdanews.com.

Share article on social media or email:

DataHow and Genedata Partner on Digitalization of Biopharma Process Development and Manufacturing


News Image

Full digitalization of production processes is at the heart of DataHow’s vision … Our collaboration with Genedata will streamline the whole biopharma lifecycle from process development to late-stage manufacturing. Alessandro Butté, CEO, DataHow AG

Genedata and DataHow, both leading innovators for the digital transformation of biopharma R&D, entered a strategic partnership to integrate their platforms to further streamline bioprocess development and manufacturing workflows. The combined solution will directly integrate DataHow’s Digital Twin products, including DataHowLab and SpectraHow, with the Genedata Biopharma Platform so that process development and manufacturing data can be seamlessly exchanged and interpreted. Having experimental data and modelling data available together will streamline digitalization across biopharma process development and manufacturing. This will enable digital tracking of data for every molecule, sample, and process for more efficient process development and integrate state-of-the-art modelling capabilities to better understand and optimize critical attributes of the biopharmaceutical manufacturing process.

DataHow’s platform provides high-performance bioprocess data analysis and predictive modelling tools based on a user-friendly workflow with customized data visualization techniques, hybrid modelling for process understanding and design, and machine-learning to enable self-learning capabilities and knowledge transfer across molecules and scales. Genedata Bioprocess® is a fully integrated biopharma R&D workflow platform, which integrates processes and connects people, data, and laboratory instruments to automate corporate-wide development and manufacturing operations. It supports the entire end-to-end (E2E) process, covering cell line development (CLD), upstream process development (USP), downstream process development (DSP), formulation development (FD), process analytical support, and analytical development (AD). The integration of the platforms results in synergies that further drive harmonization and automation along the full process. Additionally, as part of the collaboration, DataHow and Genedata will expand the integrated platform to other innovation areas in process development and manufacturing, including hybrid model-supported process monitoring and control with Raman Spectroscopy and E2E applications of Digital Twins.

“The development of innovative biotherapeutics, including cell and gene therapies and next-generation vaccines, is based on extremely complex and data-rich R&D processes,” noted Othmar Pfannes, Ph.D., CEO of Genedata. “The Genedata Biopharma Platform enables full automation of experimental workflows due to its flexible data model and open programming interfaces. It also allows emerging technology leaders such as DataHow to integrate their technology platform, minimizing setup and integration work for joint customers and directly creating value out of the generated data. This integration provides the best of both worlds — fully automated high-throughput processes complemented by a comprehensive modelling platform supporting faster and better decision making for process development and manufacturing.”

“Full digitalization of production processes is at the heart of DataHow’s vision. Digitalization will allow users to perform a large majority of tasks related to manufacturing processes in silico and automated. This includes process predictive monitoring, optimization, scenario and deviation analysis, and quality management,” said Alessandro Butté, CEO of DataHow AG. “Both companies share a common vision — providing the biopharma industry with one holistic platform that seamlessly communicates between all involved stakeholders, allowing to manage bioprocess data and knowledge in a comprehensible digital format. Our collaboration with Genedata will streamline the whole biopharma lifecycle from process development to late-stage manufacturing.”

About DataHow

DataHow is a software provider focused on accelerating process development, optimizing manufacturing processes, and increasing robustness by using hybrid modeling solutions. Our software and services are tailored to upstream (cell culture, fermentation, seed train, etc.) and downstream (chromatography, ultrafiltration, diafiltration, etc.) biopharma operations providing the user with essential insights for process development, characterization, and scale-up. Our unique Digital Twin technology allows to handle all process units and their interactions, and to transfer knowledge between scales, projects, and product targets. With our approach we want to support the decision process of process experts, scientists, and operators by leveraging in our technology all available process data and knowledge. DataHow was incorporated in 2017 as a spin-off from ETH Zurich and operates with 45 team members across 3 continents.

http://www.datahow.ch

LinkedIn

About Genedata

Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.

http://www.genedata.com

LinkedIn| Twitter| YouTube

________________________________________

Contact

Allison Kurz

Genedata

Public Relations

pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Share article on social media or email:



Embry-Riddle Named Best in West, Best for Vets, Most Innovative by U.S. News & World Report


U.S. News & World Report most recently ranked Embry-Riddle’s Prescott Campus No. 1 for Best Regional College in the West, Best for Vets (West) and Most Innovative School (West).

“Our No. 1 priority is personal attention to student success. This independent ranking underscores our unwavering commitment to prepare tomorrow’s leaders in aviation, aerospace, business, cybersecurity, engineering and STEM fields.” – Embry-Riddle President P. Barry Butler, Ph.D.

“U.S. News & World Report” named Embry-Riddle Aeronautical University No. 1 in three separate categories in this year’s rankings of residential campuses, recognizing the Prescott Campus for top marks in innovation, veteran education and overall quality in the western region of the United States:


  • No. 1: Best Regional Colleges (Regional — West)
  • No. 1: Best for Veterans (Regional — West)
  • No. 1: Most Innovative Schools (Regional — West)

After appearing in the overall Best Regional Colleges (West) category for the first time last year, at No. 2, Embry-Riddle’s Prescott Campus rose to the No. 1 spot this year. This also marked the second consecutive year that the campus has ranked No. 1 in the Best for Veterans category — last year was the first time the college applied for consideration, also earning the top spot — based on metrics such as student engagement, faculty credentials and training, expert opinion and student services/technology.

Earlier this year, Embry-Riddle’s Worldwide Campus, which administers the university’s virtual-learning programs, was named the best in the nation for its online bachelor’s programs and its online bachelor’s programs for veterans, the latter of which claimed the top spot in the rankings for the seventh straight year.

“Our No. 1 priority is personal attention to student success,” Embry-Riddle President P. Barry Butler, Ph.D., said. “This independent ranking underscores our unwavering commitment to prepare tomorrow’s leaders in aviation, aerospace, business, cybersecurity, engineering and STEM fields.”

The Prescott Campus also ranked No. 2 in the Best Undergraduate Aerospace Engineering Programs category (for schools without a Ph.D. option) and No. 5 for Best Value Schools.

“Being an Embry-Riddle Eagle opens doors,” Dr. Anette Karlsson, Prescott Campus chancellor said. “Students have the opportunity to work on real-world problems and deliver industry-ready solutions. These latest rankings confirm yet again that our faculty and staff go above and beyond to help our students develop into confident, capable leaders that are fast-tracked to career success.”

Embry-Riddle’s Daytona Beach Campus brought home high marks, too, earning top-10 finishes in the Most Innovative Schools (South), No. 2, category; Best for Veterans (South), No.4; and Best Undergraduate Engineering Program (for schools with a doctoral option), No. 8.

Share article on social media or email:

Benchmark Named to Best Workplaces in Aging Services List by FORTUNE Magazine, Recertified as a Great Place to Work®


News Image

“Benchmark remains committed to an employee experience that values and recognizes everyone’s contributions, while also providing them the resources necessary to grow professionally and within Benchmark.” -Tom Grape, founder, chairman and CEO of Benchmark

Benchmark, the largest senior housing provider in New England, today announced that it was certified as a Great Place To Work for the fifth straight year and ranked 17th nationally as a Best Workplaces in Aging Services by FORTUNE magazine.

More than 4,400 Benchmark employees completed the Great Place to Work survey, the results of which determined recertification and a spot on FORTUNE’s list of large senior housing and care providers with more than 1,000 employees.

“It’s our dedicated and compassionate associates who make Benchmark such a special place to work – a great place to work. They have created a welcoming and supportive environment for each other and, of course, for our residents,” said Tom Grape, founder, chairman and CEO of Benchmark. “Benchmark remains committed to an employee experience that values and recognizes everyone’s contributions, while also providing them the resources necessary to grow professionally and within Benchmark.”

The Great Place to Work survey gauges employees’ perceptions in five areas – pride, respect, credibility, fairness and camaraderie – with employee engagement and culture being critical criteria. The level of trust felt toward company leaders, pride taken in their jobs and camaraderie experienced with co-workers are all considered.

In addition to offering a wide range of benefits, inclusion, incentive, recognition and associate appreciation programs, Benchmark is known for its many career development opportunities provided by Benchmark University. The Benchmark One Company Fund, a 501(c)(3) organization, is there for associates in times of need when they can’t purchase the necessities of life or meet the contingencies created by an emergency.

This award is one of many accolades Benchmark has received this year and since its inception. Earlier this year, its communities received 53 U.S. News & World Report Best Independent Living, Best Assisted Living and Best Memory Care awards in its inaugural Best Senior Living 2022-2023 excellence program. Since 1997, the company has won over 200 local, regional and national awards for its care, programs and as a top workplace. Among them is the Boston Globe’s Top Places to Work employee-based survey for 14 straight years.

For the complete list of the 2022 Great Places to Work in Aging Services companies, visit https://www.greatplacetowork.com/best-workplaces/aging-services/2022.

# # #

About Benchmark

Benchmark is New England’s largest senior living provider with 64 independent living, assisted living, memory care and continuing care communities and over 5,000 dedicated associates providing compassionate care and outstanding experiences throughout the Northeast. The Waltham, Mass.-based company was founded over 25 years ago by Tom Grape with the purpose of Transforming Lives Through Human Connection. Since then, Benchmark has continued to set the industry standard, having won over a hundred local, regional and national awards for its care, programs and as a top workplace. Benchmark has been named one of the Top Places to Work for 14 straight years in The Boston Globe’s annual employee-based survey and received repeated recognition in FORTUNE’s Best Workplaces for Aging Services list. For more information, visit BenchmarkSeniorLiving.com.

Share article on social media or email:

Long Island Psychology Adds a New Office in Roslyn and a New Therapist


“Convenience always plays a role in commitment”

Long Island Psychology is a local psychotherapy group serving Nassau County on Long Island, with offices located near Queens and Suffolk County, NY. They offer individual therapy, couples counseling and group therapy for patients of all ages that are interested in addressing their mental health challenges.

Long Island Psychology has two offices in Garden City and Rockville Centre. They are pleased to announce that they are opening a third office in Roslyn Heights, NY.

“Over the past few years, we’ve really seen an increase in the number of individuals who want to, and are ready to, improve their mental health, and want to do so with therapists that see them as unique individuals,” says Dr. Marc Shulman, founder of Long Island Psychology, “but, no matter how determined someone is, convenience always plays a role in commitment. Our hope is that this third office will make therapy within reach, helping those in nearby areas get the help they need at a place that is closer to them and one in which they are more familiar.”

Located at 70 Glen Cove Road, Suite 207, this new office will be easier to reach for current and future patients in places like Manhasset, Brookville, Great Neck, Lake Success, Jericho, Syosset, Plainview and other nearby towns. The offices in Garden City and Rockville Centre will also continue to see new and existing clients, and remote therapy will always be available to anyone in New York state no matter their location.

In addition to the new office, Long Island Psychology is thrilled to announce that Jennifer Hersh Zurndorfer, LCSW-R, a talented clinical social worker, will be joining their team to provide individual therapy and couples counseling for men, women, and children of all ages.

“Jennifer is a skilled therapist,” says Dr. Shulman. “We could not be happier to have her on board, and know that she’s going to bring a lot of value to those that are struggling with her insights and abilities.”

Long Island Psychology uses several treatment modalities, including Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, Mindfulness, Psychodynamic techniques, Gottman methods, Positive Psychology, and other therapies. Their therapists also provide couples counseling and both child and adolescent therapy. For more information about their mental health services, they can be reached at tel: (516) 732-0273.

About Long Island Psychology: Long Island Psychology provides individual and couples therapy that focuses on anxiety, depression, addictions, relationships and other mental health conditions. They have offices in Garden City, Rockville Centre, and Roslyn Heights. They are also available for remote therapy through video technology for clients anywhere in New York State. Visit their website at http://www.lipsychologist.com.

Share article on social media or email:

Director of Business Development for Aspen Biosciences


Dr. Mary Canady Joins Aspen Biosciences as Director of Business Development

Dr. Mary Canady Joins Aspen Biosciences as Director of Business Development

Aspen Biosciences CEO Mark Fortner: Dr. Canady will empower our customers to connect, learn and advance their drug discovery programs by building communities of practice around our products and services.

Aspen Biosciences is pleased to welcome Dr. Mary Canady to its leadership team. Canady is a successful, connected, entrepreneur, life science Marketing and Communications Director, Biotech Community Builder, Diversity / Inclusion Advocate and Keynote Speaker. As Director of Business Development, her focus is on cultivating and growing Aspen Biosciences’ business and establishing it as a life sciences industry leader of customized software solutions.

Before joining Aspen Biosciences, Canady founded Biotech Networks, a next generation networking organization dedicated to building bridges between academic and industrial life science organizations and professionals. San Diego Biotech Network s (SDBN) began connecting life science professionals in 2008. Over the years, Biotech Networks has grown to include hubs in San Francisco and Los Angeles, California; Washington State / Oregon; Boston / Cambridge; Pennsylvania / NY / NY; DC / Maryland / Virginia; North Carolina; Utah / Colorado; and Texas.

Canady also founded Comprendia in 2008, where her leadership enabled over 30 life science companies to meet their goals through traditional, digital, and social media strategies, tactics, and training. Throughout her work, she has led scientists to excel in the digital realm through the development of scientific software solutions and by furthering their engagement in online communication.

Canady brings with her a Ph.D. in Biochemistry where she focused on structural biology, an essential step in the therapeutics development process. She has successfully led business development and marketing teams at drug discovery contract research organizations. Concurrently, Biotech Networks has been pivotal in empowering small to midsize life science organizations to enter the drug discovery arena, an area which was previously reserved for larger pharmaceutical companies. Biotech Networks’ online directories and tools, educational events, news and jobs feeds, and networking events all contribute to forming a strong and supportive community.

“We are excited to have Dr. Canady join the Aspen Biosciences team. There is a perfect synergy between her background and our mission to connect people, processes and technologies to solve drug discovery and diagnostic challenges,” said Mark Fortner, CEO. “Dr. Canady will empower our customers to connect, learn and advance their drug discovery programs by building communities of practice around our products and services.”

Throughout her career, Canady has held several top level positions, has demonstrated success in strategic and tactical marketing, and has made it her life’s mission to empower scientists to make a bigger impact. She is recognized in the Life Science industry as a thought leader and continues to be passionate about diversity, equality and inclusion for STEM professionals.

About Aspen Biosciences

Aspen Biosciences is a leading provider of scientific software and informatics solutions for drug discovery, diagnostic and research organizations. We use our extensive experience in life sciences, drug discovery and agile software development to provide solutions for improving discovery speed, scaling projects, and reducing data management tasks required for therapeutics programs. Services include informatics roadmaps, custom software solutions, ELN/LIMS implementations, system integrations and lab automations and our mission is to accelerate your life science R&D efforts.

Share article on social media or email:

Global Wellness Institute (GWI) Spotlights Thailand’s Unique Wellness Assets on New “Geography of Wellness” Platform


News Image

“GWI’s ”Geography of Wellness” is a platform that was created to give countries a deeper understanding of where they are positioned within the $4.4 trillion wellness economy

The nonprofit Global Wellness Institute (GWI), the leading research and educational resource for the $4.4 trillion global wellness industry, today announced Thailand as the third country to be spotlighted on its new “Geography of Wellness” microsite. Singapore and Brazil were the first two countries added to the newly launched resource that went live in May.

This deep dive into Thailand’s wellness economy data is thanks to BDMS Wellness Clinic, the flagship wellness center from Thailand’s largest private healthcare network, Bangkok Dusit Medical Services (BDMS). BDMS Wellness Clinic operates on the simple philosophy that prevention is better than cure and uses advanced science and technology to help physicians predict future health issues and prevent disease, while also enhancing mental and physical performance.

“GWI’s ”Geography of Wellness” is a platform that was created to give countries a deeper understanding of where they are positioned within the $4.4 trillion wellness economy,” said Susie Ellis, GWI chair and CEO. “This gives entrepreneurs, businesses, academics and government agencies a clear-eyed look at where short- and long-term opportunities may lie. Our thanks go out to country partners, like BDMS Wellness Clinic, for recognizing the value of these insights.”

According to GWI data, Thailand’s wellness economy grew an impressive 29% between 2017 to 2019. This growth understandably stagnated and retracted under the pandemic’s strict travel restrictions because a large portion of Thailand’s wellness economy had come from Wellness Tourism and Spas, two sectors that were hit hard.

For context, GWI researchers say the overall global wellness economy grew from $4.3 trillion in 2017 to $4.9 trillion in 2019, or by 6.6%, significantly higher than global economic growth (4%); but, in 2020, the wellness economy fell by 11% to $4.4 trillion and was harder hit than global GDP, which fell by 2.8%.

GWI’s macro wellness economy market data, along with a deep dive into the Asia-Pacific region and Thailand specifically, can be found in the newly released report, “The Global Wellness Economy: Thailand,” which is available for free download thanks to BDMS’ partnership.

“Of the 11 sectors GWI measures, one of the biggest gainers through the pandemic was the ‘Public Health, Prevention & Personalized Medicine’ sector, which grew 6.5% from 2019 to 2020,” said Dr. Tanupol Virunhagarun, Chief Executive Officer of BDMS Wellness Clinic. “BDMS is honored to have played a significant role in that growth.”

“We see our partnership with GWI as a tangible way to give back to the local wellness community by fostering deeper knowledge about Thailand’s unique wellness assets and helping to create a roadmap to grow our country’s slice of the growing wellness economy,” continued Dr. Virunhagarun.

Today, Thailand’s overall position in the Asia-Pacific wellness economy is currently #9, while its global ranking is #24.

GWI researchers latest report, “The Global Wellness Economy: Looking Beyond Covid(1),” forecasts that the wellness economy is on track to expand to $7 trillion by 2025. Thailand’s 2020 global ranking in the 11 wellness sectors (among the 218 countries where GWI collects data) illustrates a huge opportunity for growth, especially with tourism and travel rebounding.

Wellness in Thailand

Thailand is known not only as a top travel destination with its tropical islands, cuisine, cultural richness and bustling markets, but it also is well-regarded for its world-class holistic wellness and health retreats. With well-established tourism, medical and wellness sectors, Thailand caters to both tourists and locals alike who are looking for the best in health and wellness. The popularity of the country’s traditional therapies and herbal remedies has made “Thai massage” a treatment coveted the world over.

Thailand has also emerged as a leader in medical wellness and is very well regarded for its comprehensive preventive checkups and wellness retreats, making it an ideal destination for anyone seeking world-class health and wellness services at cost-effective prices.

[NOTE: GWI is currently working with numerous country partners to highlight their country’s unique wellness assets and will continue to announce new country reports as they are added to the platform.]

About the Global Wellness Institute: The Global Wellness Institute (GWI), a nonprofit 501(c)(3), is considered the leading global research and educational resource for the global wellness industry and is known for introducing major industry initiatives and regional events that bring together leaders to chart the future. GWI positively impacts global health and wellness by educating public institutions, businesses and individuals on how they can work to prevent disease, reduce stress and enhance the overall quality of life. Its mission is to empower wellness worldwide.

(1) https://globalwellnessinstitute.org/press-room/press-releases/2021-gwi-research-report/

Share article on social media or email: